FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 336:597-604 February 27, 1997 Number 9 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

ABSTRACT

Background Neonates with pulmonary hypertension have been treated with inhaled nitric oxide because of studies suggesting that it is a selective pulmonary vasodilator. We conducted a randomized, multicenter, controlled trial to determine whether inhaled nitric oxide would reduce mortality or the initiation of extracorporeal membrane oxygenation in infants with hypoxic respiratory failure.

Methods Infants born after a gestation of >34 weeks who were 14 days old or less, had no structural heart disease, and required assisted ventilation and whose oxygenation index was 25 or higher on two measurements were eligible for the study. The infants were randomly assigned to receive nitric oxide at a concentration of 20 ppm or 100 percent oxygen (as a control). Infants whose partial pressure of arterial oxygen (PaO₂) increased by 20 mm Hg or less after 30 minutes were studied for a response to 80-ppm nitric oxide or control gas.

Results The 121 infants in the control group and the 114 in the nitric oxide group had similar base-line clinical characteristics. Sixty-four percent of the control group and 46 percent of the nitric oxide group died within 120 days or were treated with extracorporeal membrane oxygenation (P = 0.006). Seventeen percent of the control group and 14 percent of the nitric oxide group died (P not significant), but significantly fewer in the nitric oxide group received extracorporeal membrane oxygenation (39 percent vs. 54 percent, P = 0.014). The nitric oxide group had significantly greater improvement in PaO₂ (mean [±SD] increase, 58.2±85.2 mm Hg, vs. 9.7±51.7 mm Hg in the controls; P<0.001) and in the oxygenation index (a decrease of 14.1±21.1, vs. an increase of 0.8±21.1 in the controls; P<0.001). The study gas was not discontinued in any infant because of toxicity.

Conclusions Nitric oxide therapy reduced the use of extracorporeal membrane oxygenation, but had no apparent effect on mortality, in critically ill infants with hypoxic respiratory failure.

Source Information

Dr. Ehrenkranz, as co-principal investigator of the study, assumes responsibility for the overall content and integrity of the article.

Address reprint requests to Dr. Richard A. Ehrenkranz at the Department of Pediatrics, Yale University School of Medicine, P.O. Box 208064, 333 Cedar St., New Haven, CT 06520-8064.

Full Text of this Article

This article has been cited by other articles:

• Watson, R. S., Clermont, G., Kinsella, J. P., Kong, L., Arendt, R. E., Cutter, G., Linde-Zwirble, W. T., Abman, S. H., Angus, D. C., on behalf of the Prolonged Outcomes After Nitric O, (2009). Clinical and Economic Effects of iNO in Premature Newborns With Respiratory Failure at 1 Year. Pediatrics 124: 1333-1343 [Abstract] [Full Text]  
• Chester, M., Tourneux, P., Seedorf, G., Grover, T. R., Gien, J., Abman, S. H. (2009). Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus. Am. J. Physiol. Lung Cell. Mol. Physiol. 297: L318-L325 [Abstract] [Full Text]  
• Pesaturo, K. A., Johnson, P. N., Ramsey, E. Z. (2009). Pediatric Pulmonary Hypertension: A Pharmacotherapeutic Review. Journal of Pharmacy Practice 22: 166-178 [Abstract]  
• Pawlik, T. D., Porta, N. F. M., Steinhorn, R. H., Ogata, E., deRegnier, R.-A. O. (2009). Medical and Financial Impact of a Neonatal Extracorporeal Membrane Oxygenation Referral Center in the Nitric Oxide Era. Pediatrics 123: e17-e24 [Abstract] [Full Text]  
• Farrow, K. N., Lakshminrusimha, S., Reda, W. J., Wedgwood, S., Czech, L., Gugino, S. F., Davis, J. M., Russell, J. A., Steinhorn, R. H. (2008). Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 295: L979-L987 [Abstract] [Full Text]  
• Woldesenbet, M, Rosenfeld, C R, Ramilo, O, Johnson-Welch, S, Perlman, J M (2008). Severe neonatal hypoxic respiratory failure correlates with histological chorioamnionitis and raised concentrations of interleukin 6 (IL6), IL8 and C-reactive protein. Arch. Dis. Child. Fetal Neonatal Ed. 93: F413-F417 [Abstract] [Full Text]  
• McNamara, P. J., Murthy, P., Kantores, C., Teixeira, L., Engelberts, D., van Vliet, T., Kavanagh, B. P., Jankov, R. P. (2008). Acute vasodilator effects of Rho-kinase inhibitors in neonatal rats with pulmonary hypertension unresponsive to nitric oxide. Am. J. Physiol. Lung Cell. Mol. Physiol. 294: L205-L213 [Abstract] [Full Text]  
• Farrow, K. N., Groh, B. S., Schumacker, P. T., Lakshminrusimha, S., Czech, L., Gugino, S. F., Russell, J. A., Steinhorn, R. H. (2008). Hyperoxia Increases Phosphodiesterase 5 Expression and Activity in Ovine Fetal Pulmonary Artery Smooth Muscle Cells. Circ. Res. 102: 226-233 [Abstract] [Full Text]  
• Gamboa, D., Robbins, D., Saba, Z. (2007). Bleeding After Circumcision in a Newborn Receiving Sildenafil. CLIN PEDIATR 46: 842-843 [Abstract]  
• Bloch, K. D., Ichinose, F., Roberts, J. D. Jr., Zapol, W. M. (2007). Inhaled NO as a therapeutic agent. Cardiovasc Res 75: 339-348 [Abstract] [Full Text]  
• Steinhorn, R. H, Farrow, K. N (2007). Pulmonary Hypertension in the Neonate. NeoReviews 8: e14-e21 [Abstract] [Full Text]  
• Lakshminrusimha, S., Russell, J. A., Wedgwood, S., Gugino, S. F., Kazzaz, J. A., Davis, J. M., Steinhorn, R. H. (2006). Superoxide Dismutase Improves Oxygenation and Reduces Oxidation in Neonatal Pulmonary Hypertension. Am. J. Respir. Crit. Care Med. 174: 1370-1377 [Abstract] [Full Text]  
• George, I., Xydas, S., Topkara, V. K., Ferdinando, C., Barnwell, E. C., Gableman, L., Sladen, R. N., Naka, Y., Oz, M. C. (2006). Clinical Indication for Use and Outcomes After Inhaled Nitric Oxide Therapy. Ann. Thorac. Surg. 82: 2161-2169 [Abstract] [Full Text]  
• Namachivayam, P., Theilen, U., Butt, W. W., Cooper, S. M., Penny, D. J., Shekerdemian, L. S. (2006). Sildenafil Prevents Rebound Pulmonary Hypertension after Withdrawal of Nitric Oxide in Children. Am. J. Respir. Crit. Care Med. 174: 1042-1047 [Abstract] [Full Text]  
• Sheffield, M., Mabry, S., Thibeault, D. W., Truog, W. E. (2006). Pulmonary Nitric Oxide Synthases and Nitrotyrosine: Findings During Lung Development and in Chronic Lung Disease of Prematurity. Pediatrics 118: 1056-1064 [Abstract] [Full Text]  
• Ballard, R. A., Truog, W. E., Cnaan, A., Martin, R. J., Ballard, P. L., Merrill, J. D., Walsh, M. C., Durand, D. J., Mayock, D. E., Eichenwald, E. C., Null, D. R., Hudak, M. L., Puri, A. R., Golombek, S. G., Courtney, S. E., Stewart, D. L., Welty, S. E., Phibbs, R. H., Hibbs, A. M., Luan, X., Wadlinger, S. R., Asselin, J. M., Coburn, C. E., the NO CLD Study Group, (2006). Inhaled nitric oxide in preterm infants undergoing mechanical ventilation.. NEJM 355: 343-353 [Abstract] [Full Text]  
• Kinsella, J. P., Cutter, G. R., Walsh, W. F., Gerstmann, D. R., Bose, C. L., Hart, C., Sekar, K. C., Auten, R. L., Bhutani, V. K., Gerdes, J. S., George, T. N., Southgate, W. M., Carriedo, H., Couser, R. J., Mammel, M. C., Hall, D. C., Pappagallo, M., Sardesai, S., Strain, J. D., Baier, M., Abman, S. H. (2006). Early inhaled nitric oxide therapy in premature newborns with respiratory failure.. NEJM 355: 354-364 [Abstract] [Full Text]  
• Stanley, K. P., Chicoine, L. G., Young, T. L., Reber, K. M., Lyons, C. R., Liu, Y., Nelin, L. D. (2006). Gene transfer with inducible nitric oxide synthase decreases production of urea by arginase in pulmonary arterial endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L298-L306 [Abstract] [Full Text]  
• Khambekar, K, Nichani, S, Luyt, D K, Peek, G, Firmin, R K, Field, D J, Pandya, H C (2006). Developmental outcome in newborn infants treated for acute respiratory failure with extracorporeal membrane oxygenation: present experience. Arch. Dis. Child. Fetal Neonatal Ed. 91: F21-F25 [Abstract] [Full Text]  
• (2005). Additional Information. JAMA 294: E1-E3 [Full Text]  
• Deruelle, P., Grover, T. R., Abman, S. H. (2005). Pulmonary vascular effects of nitric oxide-cGMP augmentation in a model of chronic pulmonary hypertension in fetal and neonatal sheep. Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L798-L806 [Abstract] [Full Text]  
• Bland, R. D., Albertine, K. H., Carlton, D. P., MacRitchie, A. J. (2005). Inhaled Nitric Oxide Effects on Lung Structure and Function in Chronically Ventilated Preterm Lambs. Am. J. Respir. Crit. Care Med. 172: 899-906 [Abstract] [Full Text]  
• Van Meurs, K. P., Wright, L. L., Ehrenkranz, R. A., Lemons, J. A., Ball, M. B., Poole, W. K., Perritt, R., Higgins, R. D., Oh, W., Hudak, M. L., Laptook, A. R., Shankaran, S., Finer, N. N., Carlo, W. A., Kennedy, K. A., Fridriksson, J. H., Steinhorn, R. H., Sokol, G. M., Konduri, G. G., Aschner, J. L., Stoll, B. J., D'Angio, C. T., Stevenson, D. K., the Preemie Inhaled Nitric Oxide Study, (2005). Inhaled Nitric Oxide for Premature Infants with Severe Respiratory Failure. NEJM 353: 13-22 [Abstract] [Full Text]  
• Van Meurs, K. P. (2005). Inhaled Nitric Oxide Therapy in the Preterm Infant Who Has Respiratory Distress Syndrome. NeoReviews 6: e268-e277 [Full Text]  
• Lee, J. W., Gonzalez, R. F., Chapin, C. J., Busch, J., Fineman, J. R., Gutierrez, J. A. (2005). Nitric oxide decreases surfactant protein gene expression in primary cultures of type II pneumocytes. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L950-L957 [Abstract] [Full Text]  
• Deruelle, P., Grover, T. R., Storme, L., Abman, S. H. (2005). Effects of BAY 41-2272, a soluble guanylate cyclase activator, on pulmonary vascular reactivity in the ovine fetus. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L727-L733 [Abstract] [Full Text]  
• Ross, G. A., Oishi, P., Azakie, A., Fratz, S., Fitzgerald, R. K., Johengen, M. J., Harmon, C., Hendricks-Munoz, K., Xu, J., Black, S. M., Fineman, J. R. (2005). Endothelial alterations during inhaled NO in lambs with pulmonary hypertension: implications for rebound hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L27-L35 [Abstract] [Full Text]  
• Inglessis, I., Shin, J. T., Lepore, J. J., Palacios, I. F., Zapol, W. M., Bloch, K. D., Semigran, M. J. (2004). Hemodynamic effects of inhaled nitric oxide in right ventricular myocardial infarction and cardiogenic shock. J Am Coll Cardiol 44: 793-798 [Abstract] [Full Text]  
• Lorch, S. A., Cnaan, A., Barnhart, K. (2004). Cost-Effectiveness of Inhaled Nitric Oxide for the Management of Persistent Pulmonary Hypertension of the Newborn. Pediatrics 114: 417-426 [Abstract] [Full Text]  
• Badesch, D. B., Abman, S. H., Ahearn, G. S., Barst, R. J., McCrory, D. C., Simonneau, G., McLaughlin, V. V. (2004). Medical Therapy For Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines. Chest 126: 35S-62S [Abstract] [Full Text]  
• Ichinose, F., Roberts, J. D. Jr, Zapol, W. M. (2004). Inhaled Nitric Oxide: A Selective Pulmonary Vasodilator: Current Uses and Therapeutic Potential. Circulation 109: 3106-3111 [Full Text]  
• Prodhan, P., Noviski, N. (2004). Pediatric Acute Hypoxemic Respiratory Failure: Management of Oxygenation. J Intensive Care Med 19: 140-153 [Abstract]  
• Thelitz, S., Bekker, J. M., Ovadia, B., Stuart, R. B., Johengen, M. J., Black, S. M., Fineman, J. R. (2004). Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs. J. Thorac. Cardiovasc. Surg. 127: 1285-1292 [Abstract] [Full Text]  
• Kelly, L. K., Wedgwood, S., Steinhorn, R. H., Black, S. M. (2004). Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase. Am. J. Physiol. Lung Cell. Mol. Physiol. 286: L984-L991 [Abstract] [Full Text]  
• Taylor, R. W., Zimmerman, J. L., Dellinger, R. P., Straube, R. C., Criner, G. J., Davis, K. Jr, Kelly, K. M., Smith, T. C., Small, R. J. (2004). Low-Dose Inhaled Nitric Oxide in Patients With Acute Lung Injury: A Randomized Controlled Trial. JAMA 291: 1603-1609 [Abstract] [Full Text]  
• Konduri, G. G., Solimano, A., Sokol, G. M., Singer, J., Ehrenkranz, R. A., Singhal, N., Wright, L. L., Van Meurs, K., Stork, E., Kirpalani, H., Peliowski, A., for the Neonatal Inhaled Nitric Oxide Study Group, (2004). A Randomized Trial of Early Versus Standard Inhaled Nitric Oxide Therapy in Term and Near-Term Newborn Infants With Hypoxic Respiratory Failure. Pediatrics 113: 559-564 [Abstract] [Full Text]  
• Angus, D. C., Clermont, G., Watson, R. S., Linde-Zwirble, W. T., Clark, R. H., Roberts, M. S. (2003). Cost-Effectiveness of Inhaled Nitric Oxide in the Treatment of Neonatal Respiratory Failure in the United States. Pediatrics 112: 1351-1360 [Abstract] [Full Text]  
• Schreiber, M. D., Gin-Mestan, K., Marks, J. D., Huo, D., Lee, G., Srisuparp, P. (2003). Inhaled Nitric Oxide in Premature Infants with the Respiratory Distress Syndrome. NEJM 349: 2099-2107 [Abstract] [Full Text]  
• Stuart, R. B., Ovadia, B., Suzara, V. V., Ross, P. A., Thelitz, S., Fineman, J. R., Gutierrez, J. A. (2003). Inhaled nitric oxide increases surfactant protein gene expression in the intact lamb. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L628-L633 [Abstract] [Full Text]  
• Bland, R. D., Ling, C. Y., Albertine, K. H., Carlton, D. P., MacRitchie, A. J., Day, R. W., Dahl, M. J. (2003). Pulmonary vascular dysfunction in preterm lambs with chronic lung disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L76-L85 [Abstract] [Full Text]  
• Gerlach, H., Keh, D., Semmerow, A., Busch, T., Lewandowski, K., Pappert, D. M., Rossaint, R., Falke, K. J. (2003). Dose-Response Characteristics during Long-Term Inhalation of Nitric Oxide in Patients with Severe Acute Respiratory Distress Syndrome: A Prospective, Randomized, Controlled Study. Am. J. Respir. Crit. Care Med. 167: 1008-1015 [Abstract] [Full Text]  
• Weiner, D. L., Hibberd, P. L., Betit, P., Cooper, A. B., Botelho, C. A., Brugnara, C. (2003). Preliminary Assessment of Inhaled Nitric Oxide for Acute Vaso-occlusive Crisis in Pediatric Patients With Sickle Cell Disease. JAMA 289: 1136-1142 [Abstract] [Full Text]  
• Qureshi, M. A., Shah, N. J., Hemmen, C. W., Thill, M. C., Kruse, J. A. (2003). Exposure of Intensive Care Unit Nurses to Nitric Oxide and Nitrogen Dioxide During Therapeutic Use of Inhaled Nitric Oxide in Adults With Acute Respiratory Distress Syndrome. Am J Crit Care 12: 147-153 [Abstract] [Full Text]  
• Widlitz, A., Barst, R.J. (2003). Pulmonary arterial hypertension in children. Eur Respir J 21: 155-176 [Abstract] [Full Text]  
• Franek, W. R., Chowdary, Y. C., Lin, X., Hu, M., Miller, E. J., Kazzaz, J. A., Razzano, P., Romashko, J. III, Davis, J. M., Narula, P., Horowitz, S., Scott, W., Mantell, L. L. (2002). Suppression of Nuclear Factor-kappa B Activity by Nitric Oxide and Hyperoxia in Oxygen-resistant Cells. J. Biol. Chem. 277: 42694-42700 [Abstract] [Full Text]  
• Pierce, C M, Peters, M J, Cohen, G, Goldman, A P, Petros, A J (2002). Cost of nitric oxide is exorbitant. BMJ 325: 336-336 [Full Text]  
• Thebaud, B., Petit, T., de Lagausie, P., Dall'Ava-Santucci, J., Mercier, J.-C., Dinh-Xuan, A. T. (2002). Altered Guanylyl-Cyclase Activity In Vitro of Pulmonary Arteries from Fetal Lambs with Congenital Diaphragmatic Hernia. Am. J. Respir. Cell Mol. Bio. 27: 42-47 [Abstract] [Full Text]  
• Wright, L. L. (2001). The Role of Follow-up in Randomized Controlled Trials. NeoReviews 2: e257-266 [Full Text]  
• MacRitchie, A. N., Albertine, K. H., Sun, J., Lei, P. S., Jensen, S. C., Freestone, A. A., Clair, P. M., Dahl, M. J., Godfrey, E. A., Carlton, D. P., Bland, R. D. (2001). Reduced endothelial nitric oxide synthase in lungs of chronically ventilated preterm lambs. Am. J. Physiol. Lung Cell. Mol. Physiol. 281: L1011-L1020 [Abstract] [Full Text]  
• Higgins, R. D, Keszler, M. (2001). Perinatal vascular development. Cardiovasc Res 51: 7-8 [Full Text]  
• Pearson, D. L., Dawling, S., Walsh, W. F., Haines, J. L., Christman, B. W., Bazyk, A., Scott, N., Summar, M. L. (2001). Neonatal Pulmonary Hypertension- Urea-Cycle Intermediates, Nitric Oxide Production, and Carbamoyl-Phosphate Synthetase Function. NEJM 344: 1832-1838 [Abstract] [Full Text]  
• Ellington Jr, M., O'Reilly, D., Allred, E. N., McCormick, M. C., Wessel, D. L., Kourembanas, S. (2001). Child Health Status, Neurodevelopmental Outcome, and Parental Satisfaction in a Randomized, Controlled Trial of Nitric Oxide for Persistent Pulmonary Hypertension of the Newborn. Pediatrics 107: 1351-1356 [Abstract] [Full Text]  
• Baldauf, M., Silver, P., Sagy, M. (2001). Evaluating the Validity of Responsiveness to Inhaled Nitric Oxide in Pediatric Patients With ARDS : An Analytic Tool. Chest 119: 1166-1172 [Abstract] [Full Text]  
• McMullan, D. M., Bekker, J. M., Johengen, M. J., Hendricks-Munoz, K., Gerrets, R., Black, S. M., Fineman, J. R. (2001). Inhaled nitric oxide-induced rebound pulmonary hypertension: role for endothelin-1. Am. J. Physiol. Heart Circ. Physiol. 280: H777-H785 [Abstract] [Full Text]  
• Weinberger, B., Laskin, D. L., Heck, D. E., Laskin, J. D. (2001). The Toxicology of Inhaled Nitric Oxide. Toxicol Sci 59: 5-16 [Abstract] [Full Text]  
• Zwischenberger, J. B., Alpard, S. K., Bidani, A. (2001). Severe respiratory failure. Ann. Thorac. Surg. 71: 394-396 [Full Text]  
• DAVIS, P J, SHEKERDEMIAN, L S (2001). Meconium aspiration syndrome and extracorporeal membrane oxygenation. Arch. Dis. Child. Fetal Neonatal Ed. 84: 1F-3 [Full Text]  
• Lee, S. K., McMillan, D. D., Ohlsson, A., Pendray, M., Synnes, A., Whyte, R., Chien, L.-Y., Sale, J., the Canadian NICU Network, (2000). Variations in Practice and Outcomes in the Canadian NICU Network: 1996-1997. Pediatrics 106: 1070-1079 [Abstract] [Full Text]  
• Committee on Fetus and Newborn, (2000). Use of Inhaled Nitric Oxide. Pediatrics 106: 344-345 [Abstract] [Full Text]  
• Roberts, J. D. Jr, Chiche, J.-D., Weimann, J., Steudel, W., Zapol, W. M., Bloch, K. D. (2000). Nitric Oxide Inhalation Decreases Pulmonary Artery Remodeling in the Injured Lungs of Rat Pups. Circ. Res. 87: 140-145 [Abstract] [Full Text]  
• Fineman, J. R. (2000). Invited commentary. Ann. Thorac. Surg. 69: 1913-1913 [Full Text]  
• CHRISTENSON, J., LAVOIE, A., O'CONNOR, M., BHORADE, S., POHLMAN, A., HALL, J. B. (2000). The Incidence and Pathogenesis of Cardiopulmonary Deterioration after Abrupt Withdrawal of Inhaled Nitric Oxide. Am. J. Respir. Crit. Care Med. 161: 1443-1449 [Abstract] [Full Text]  
• Thebaud, B., de Lagausie, P., Forgues, D., Aigrain, Y., Mercier, J.-C., Dinh-Xuan, A. T. (2000). ETA-receptor blockade and ETB-receptor stimulation in experimental congenital diaphragmatic hernia. Am. J. Physiol. Lung Cell. Mol. Physiol. 278: L923-L932 [Abstract] [Full Text]  
• FIELD, D, ELBOURNE, D. (2000). Use of inhaled nitric oxide to improve oxygenation in the neonate. Arch. Dis. Child. Fetal Neonatal Ed. 82: 257F-257 [Full Text]  
• Nakamura, T., Matsuzawa, S., Sugiura, M., Tamura, M. (2000). A randomised control study of partial liquid ventilation after airway lavage with exogenous surfactant in a meconium aspiration syndrome animal model. Arch. Dis. Child. Fetal Neonatal Ed. 82: 160F-162 [Abstract] [Full Text]  
• Clark, R. H., Kueser, T. J., Walker, M. W., Southgate, W. M., Huckaby, J. L., Perez, J. A., Roy, B. J., Keszler, M., Kinsella, J. P., The Clinical Inhaled Nitric Oxide Research Group, (2000). Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn. NEJM 342: 469-474 [Abstract] [Full Text]  
• ZHOU, Z.-H., SUN, B., LIN, K., ZHU, L.-W. (2000). Prevention of Rabbit Acute Lung Injury by Surfactant, Inhaled Nitric Oxide, and Pressure Support Ventilation. Am. J. Respir. Crit. Care Med. 161: 581-588 [Abstract] [Full Text]  
• Walsh-Sukys, M. C., Tyson, J. E., Wright, L. L., Bauer, C. R., Korones, S. B., Stevenson, D. K., Verter, J., Stoll, B. J., Lemons, J. A., Papile, L.-A., Shankaran, S., Donovan, E. F., Oh, W., Ehrenkranz, R. A., Fanaroff, A. A. (2000). Persistent Pulmonary Hypertension of the Newborn in the Era Before Nitric Oxide: Practice Variation and Outcomes. Pediatrics 105: 14-20 [Abstract] [Full Text]  
• BARRINGTON, K. J., SINGH, A. J., ETCHES, P. C., FINER, N. N. (1999). Partial Liquid Ventilation with and without Inhaled Nitric Oxide in a Newborn Piglet Model of Meconium Aspiration. Am. J. Respir. Crit. Care Med. 160: 1922-1927 [Abstract] [Full Text]  
• Sackett, D. L. (1999). Time to put the Canadian Institutes of Health Research on trial. CMAJ 161: 1414-1415 [Full Text]  
• Black, S. M., Heidersbach, R. S., McMullan, D. M., Bekker, J. M., Johengen, M. J., Fineman, J. R. (1999). Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension. Am. J. Physiol. Heart Circ. Physiol. 277: H1849-H1856 [Abstract] [Full Text]  
• Kinsella, J. P. (1999). Clinical Trials of Inhaled Nitric Oxide Therapy in the Newborn. Pediatr. Rev. 20: e110-e113 [Full Text]  
• Van Meurs, K., Lou Short, B. (1999). Congenital Diaphragmatic Hernia: The Neonatologist's Perspective. Pediatr. Rev. 20: 79e-87 [Full Text]  
• DUKARM, R. C., RUSSELL, J. A., MORIN, F. C. III, PERRY, B. J., STEINHORN, R. H. (1999). The cGMP-specific Phosphodiesterase Inhibitor E4021 Dilates the Pulmonary Circulation. Am. J. Respir. Crit. Care Med. 160: 858-865 [Abstract] [Full Text]  
• OLSCHEWSKI, H., ARDESCHIR GHOFRANI, H., WALMRATH, D., SCHERMULY, R., TEMMESFELD-WOLLBRÜCK, B., GRIMMINGER, F., SEEGER, W. (1999). Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung Fibrosis. Am. J. Respir. Crit. Care Med. 160: 600-607 [Abstract] [Full Text]  
• Davidson, D., Barefield, E. S., Kattwinkel, J., Dudell, G., Damask, M., Straube, R., Rhines, J., Chang, C.-T., the I-NO/PPHN Study Group, (1999). Safety of Withdrawing Inhaled Nitric Oxide Therapy in Persistent Pulmonary Hypertension of the Newborn. Pediatrics 104: 231-236 [Abstract] [Full Text]  
• Clark, R. H. (1999). How Do We Safely Use Inhaled Nitric Oxide?. Pediatrics 104: 296-296 [Full Text]  
• RENNIE, J M, BOKHARI, S A (1999). Recent advances in neonatology. Arch. Dis. Child. Fetal Neonatal Ed. 81: 1F-4 [Full Text]  
• Hill, L. L., Pearl, R. G. (1999). Combined inhaled nitric oxide and inhaled prostacyclin during experimental chronic pulmonary hypertension. J. Appl. Physiol. 86: 1160-1164 [Abstract] [Full Text]  
• Duncan, B. W., Hraska, V., Jonas, R. A., Wessel, D. L., Del Nido, P. J., Laussen, P. C., Mayer, J. E., Lapierre, R. A., Wilson, J. M. (1999). MECHANICAL CIRCULATORY SUPPORT IN CHILDREN WITH CARDIAC DISEASE. J. Thorac. Cardiovasc. Surg. 117: 529-542 [Abstract] [Full Text]  
• Sokol, G. M., Van Meurs, K. P., Wright, L. L., Rivera, O., Thorn, William. J. III, Chu, P. M., Sams, R. L. (1999). Nitrogen Dioxide Formation during Inhaled Nitric Oxide Therapy. Clin. Chem. 45: 382-387 [Abstract] [Full Text]  
• Banks, B. A., Seri, I., Ischiropoulos, H., Merrill, J., Rychik, J., Ballard, R. A. (1999). Changes in Oxygenation With Inhaled Nitric Oxide in Severe Bronchopulmonary Dysplasia. Pediatrics 103: 610-618 [Abstract] [Full Text]  
• Bland, R. D. (1999). Inhaled Nitric Oxide: A Premature Remedy for Chronic Lung Disease?. Pediatrics 103: 667-669 [Full Text]  
• Long, R., Light, B., Talbot, J. A. (1999). Mycobacteriocidal Action of Exogenous Nitric Oxide. Antimicrob. Agents Chemother. 43: 403-405 [Abstract] [Full Text]  
• Kusuda, S., Shishida, N., Miyagi, N., Hirabayashi, M., Kim, T.-J. (1999). Cerebral blood flow during treatment for pulmonary hypertension. Arch. Dis. Child. Fetal Neonatal Ed. 80: 30F-33 [Abstract] [Full Text]  
• Christou, H., Magnani, B., Morse, D. S., Allred, E. N., Van Marter, L. J., Wessel, D. L., Kourembanas, S. (1998). Inhaled Nitric Oxide Does Not Affect Adenosine 5'-Diphosphate-dependent Platelet Activation in Infants With Persistent Pulmonary Hypertension of the Newborn. Pediatrics 102: 1390-1393 [Abstract] [Full Text]  
• KANEKO, F. T., ARROLIGA, A. C., DWEIK, R. A., COMHAIR, S. A., LASKOWSKI, D., OPPEDISANO, R., THOMASSEN, M. J., ERZURUM, S. C. (1998). Biochemical Reaction Products of Nitric Oxide as Quantitative Markers of Primary Pulmonary Hypertension. Am. J. Respir. Crit. Care Med. 158: 917-923 [Abstract] [Full Text]  
• WEINBERGER, B., FAKHRZADEH, L., HECK, D. E., LASKIN, J. D., GARDNER, C. R., LASKIN, D. L. (1998). Inhaled Nitric Oxide Primes Lung Macrophages to Produce Reactive Oxygen and Nitrogen Intermediates. Am. J. Respir. Crit. Care Med. 158: 931-938 [Abstract] [Full Text]  
• ZHU, G. F., SUN, B., NIU, S. F., CAI, Y. Y., LIN, K., LINDWALL, R., ROBERTSON, B. (1998). Combined Surfactant Therapy and Inhaled Nitric Oxide in Rabbits with Oleic Acid-induced Acute Respiratory Distress Syndrome. Am. J. Respir. Crit. Care Med. 158: 437-443 [Abstract] [Full Text]  
• Day, R. W. (1998). Inhaled Nitric Oxide Prevents Severe Hypoxemia in Newborns With Acute Lung Disease and Pulmonary Hypertension. Pediatrics 101 : 1093-1094 [Full Text]  
• Payen, D. M. (1998). Is Nitric Oxide Inhalation a ""Cosmetic"" Therapy in Acute Respiratory Distress Syndrome?. Am. J. Respir. Crit. Care Med. 157: 1361-1362 [Full Text]  
• WHITSETT, J. A., STAHLMAN, M. T. (1998). Impact of Advances in Physiology, Biochemistry, and Molecular Biology on Pulmonary Disease in Neonates. Am. J. Respir. Crit. Care Med. 157: S67-S71 [Full Text]  
• Truog, W. E. (1998). Inhaled Nitric Oxide: A Tenth Anniversary Observation. Pediatrics 101: 696-696 [Full Text]  
• Body, S. C., Shernan, S. K. (1998). The Utility of Nitric Oxide in the Postoperative Period. SEMIN CARDIOTHORAC VASC ANESTH 2: 4-30 [Abstract]  
• Davidson, D., Barefield, E. S., Kattwinkel, J., Dudell, G., Damask, M., Straube, R., Rhines, J., Chang, C.-T., the I-NO/PPHN Study Group, (1998). Inhaled Nitric Oxide for the Early Treatment of Persistent Pulmonary Hypertension of the Term Newborn: A Randomized, Double-Masked, Placebo-Controlled, Dose-Response, Multicenter Study. Pediatrics 101: 325-334 [Abstract] [Full Text]  
• Barrington, K. J, Finer, N. N (1997). Recent advances: care of near term infants with respiratory failure. BMJ 315: 1215-1218 [Full Text]  
• Wessel, D. L., Adatia, I., Van Marter, L. J., Thompson, J. E., Kane, J. W., Stark, A. R., Kourembanas, S. (1997). Improved Oxygenation in a Randomized Trial of Inhaled Nitric Oxide for Persistent Pulmonary Hypertension of the Newborn. Pediatrics 100: e7-e7 [Abstract] [Full Text]  
• Subhedar, N V, Ryan, S W, Shaw, N J (1997). Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants. Arch. Dis. Child. Fetal Neonatal Ed. 77: 185F-190 [Abstract] [Full Text]  
• Subhedar, N V, Shaw, N J (1997). Changes in oxygenation and pulmonary haemodynamics in preterm infants treated with inhaled nitric oxide. Arch. Dis. Child. Fetal Neonatal Ed. 77: 191F-197 [Abstract] [Full Text]